Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer

Abstract Aims Adjuvant chemotherapy (ACT) plays an important role in improving the survival of stage II-III colorectal cancer (CRC) patients after curative surgery. However, the prognostic role of irregular delay of ACT (IDacT) for these patients has been less studied. Materials and methods A total...

Full description

Bibliographic Details
Main Authors: Yuanyuan Chen, Mingyue Xu, Qianwen Ye, Jia Xiang, Tianhui Xue, Tao Yang, Long Liu, Bing Yan
Format: Article
Language:English
Published: BMC 2022-06-01
Series:BMC Cancer
Subjects:
Colorectal cancer
Adjuvant chemotherapy
Delay
Disease-free survival
Online Access:https://doi.org/10.1186/s12885-022-09767-y

Internet

https://doi.org/10.1186/s12885-022-09767-y

Similar Items